Yemetil 25mg Tablet contains Chlorpromazine, a phenothiazine antipsychotic agent used primarily in the management of schizophrenia and other psychotic disorders. Chlorpromazine exerts its therapeutic effect by antagonizing dopamine D2 receptors in the brain, thereby reducing psychotic symptoms such as hallucinations, delusions, and thought disorders. Additionally, it has antiemetic, sedative, and anticholinergic properties, making it useful in controlling nausea, vomiting, and agitation. Yemetil is indicated for the treatment of schizophrenia, schizoaffective disorder, manic phases of bipolar disorder, and severe behavioral problems in children. It is also employed in the management of intractable hiccups and as adjunctive therapy in tetanus. The recommended dosage varies depending on the condition being treated and patient response, with careful titration advised to minimize adverse effects. Common side effects include sedation, orthostatic hypotension, extrapyramidal symptoms, dry mouth, and weight gain. Due to its potential for causing tardive dyskinesia and neuroleptic malignant syndrome, regular monitoring is essential. Yemetil should be used cautiously in patients with cardiovascular disorders, liver impairment, and a history of seizures. It is contraindicated in individuals with hypersensitivity to phenothiazines and in comatose states. Patient adherence and periodic evaluation are critical to optimize therapeutic outcomes and minimize risks.